Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q4 2022